Is AMDVX or JNJ a better dividend investment in 2026?

AMDVX currently yields 14.38% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: AMDVX offers higher current income.

What is the dividend yield difference between AMDVX and JNJ?

AMDVX has a forward dividend yield of 14.38% ($2.18/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 12.24 percentage points.

Home › Compare › AMDVX vs JNJ

AMDVX vs JNJ: Dividend Comparison 2026

AMDVX yields 14.38% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AMDVX wins by $20.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

AMDVX

● Live price

14.38%

Share price

$15.16

Annual div

$2.18

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$51.4K

Annual income

$3,500.70

Full AMDVX calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — AMDVX vs JNJ

📍 AMDVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AMDVX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AMDVX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AMDVX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMDVX

Annual income on $10K today (after 15% tax)

$1,222.07/yr

After 10yr DRIP, annual income (after tax)

$2,975.60/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, JNJ beats the other by $1,061.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMDVX + JNJ for your $10,000?

AMDVX: 50%JNJ: 50%

100% JNJ50/50100% AMDVX

Portfolio after 10yr

$40.9K

Annual income

$4,125.29/yr

Blended yield

10.08%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AMDVX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMDVX buys

JNJ buys

No recent congressional trades found for AMDVX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAMDVXJNJ

Forward yield	14.38% ✓	2.14%
Annual dividend / share	$2.18	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$51.4K ✓	$30.5K
Annual income after 10y	$3,500.70	$4,749.88 ✓
Total dividends collected	$24.2K ✓	$15.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: AMDVX vs JNJ ($10,000, DRIP)

Year	AMDVX Portfolio	AMDVX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,138	$1,437.73	$10,594	$274.49	+$1.5K → AMDVX
2	$14,618	$1,630.91	$11,294	$360.69	+$3.3K → AMDVX
3	$17,477	$1,835.72	$12,133	$476.91	+$5.3K → AMDVX
4	$20,752	$2,051.16	$13,156	$635.42	+$7.6K → AMDVX
5	$24,481	$2,276.14	$14,432	$854.61	+$10.0K → AMDVX
6	$28,704	$2,509.47	$16,056	$1,162.76	+$12.6K → AMDVX
7	$33,463	$2,749.88	$18,175	$1,604.53	+$15.3K → AMDVX
8	$38,801	$2,996.09	$21,009	$2,252.68	+$17.8K → AMDVX
9	$44,764	$3,246.79	$24,911	$3,229.73	+$19.9K → AMDVX
10	$51,398	$3,500.70	$30,458	$4,749.88	+$20.9K → AMDVX

AMDVX vs JNJ: Complete Analysis 2026

AMDVX — Stock

Under normal market conditions, the portfolio managers will invest at least 80% of the fund's net assets in medium size companies. The portfolio managers consider medium size companies to include those whose market capitalizations at the time of purchase are within the capitalization range of the Russell 3000® Index, excluding the largest 100 such companies.

Full AMDVX Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this AMDVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMDVX vs SCHD AMDVX vs JEPI AMDVX vs O AMDVX vs KO AMDVX vs MAIN AMDVX vs ABBV AMDVX vs MRK AMDVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.